Importantly, this suggests that the higher observed proportion of IFNγ and IFNγ-expressing cells in combination-treated tumors from our study are indicative of not only reduced tumor growth in mice but is more likely to be clinically translatable to patient outcomes. Here, IFNG is linked to neoplasm.